Principal,Data&Analytics

Since its inception in 2014, Roivant Sciences has sought to improve health by rapidly delivering innovative medicines and technologies to patients. We've employed a unique, decentralized model of nimble, focused companies ("Vants") centered on innovation in drug development and technology. Five new medicines have been approved off the Roivant platform, we've built multiple biotechs that have become public companies, and we've created substantial value across the platform spanning computational drug discovery, healthcare data exchange, and novel therapeutic platforms. Roivant Health is Roivant’s platform for the creation of new technology Vants, focused on delivering improvements to human health outside of our traditional biotech platform. In six years since inception, we’ve created eight enduring companies and over $1B in enterprise value, including the leading deidentified healthcare data exchange platform (Datavant) and a top-tier computational drug discovery company (VantAI) which has partnered with Johnson surface and contextualize them for leadership before they become surprises Pressure-test clinical assumptions: challenge endpoint choices, scrutinize statistical analysis plans, and flag where the data does not support the narrative Execute focused 1-5 day analytical sprints on the highest-priority questions from Roivant and Vant leadership Evidence Synthesis you do not stop at a plausible one Strong quantitative foundation and fluency with data; you have used both to answer hard questions under pressure, not just to describe what happened Genuine curiosity about science, medicine, or health; deep biology training is not required, but the underlying questions need to matter to you Fast learner who gets up to speed in unfamiliar domains without needing a runway; you are comfortable operating at the edge of your knowledge A track record of doing work that changed a decision or outcome, not just informed one Able to communicate complex findings with clarity and c